AMA Issues CPT Code for bioAffinity Technologies' CyPath® Lung Test for Early-Stage Lung Cancer | Business
SAN ANTONIO, Texas--(BUSINESS WIRE)--Jul 12, 2023--
Stay updated with breaking news from Precision Pathology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN ANTONIO, Texas--(BUSINESS WIRE)--Jul 12, 2023--
BioAffinity Technologies, Inc. , a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer, today announced that the American Medical Association has released...
SAN ANTONIO, Texas--(BUSINESS WIRE)--Jul 12, 2023--
BioAffinity Technologies, Inc. , a biotechnology company addressing the need for early-stage cancer detection and broad-spectrum cancer therapeutics, will present the poster “Vitamin B12... | June 15, 2023
BioAffinity Technologies, Inc. , a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today will present the poster... | May 22, 2023